Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
Public ClinicalTrials.gov record NCT02679573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate the Safety and Efficacy of Intravenous to Oral Delafloxacin in Adult Subjects With Community-Acquired Bacterial Pneumonia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of delafloxacin compared to moxifloxacin in the treatment of adult patients with community-acquired pneumonia.
Study identification
- NCT ID
- NCT02679573
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 860 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 14, 2016 (Actual)
- Primary completion
- Jul 31, 2018 (Actual)
- Completion
- Aug 7, 2018 (Actual)
- Last update posted
- Feb 27, 2020
2016 – 2018
United States locations
- U.S. sites
- 25
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Melinta 306 Study Site | Montgomery | Alabama | 36106 | — |
| Melinta 306 Study Site | Newark | Delaware | 19718 | — |
| Melinta 306 Study Site | Coral Gables | Florida | 33134 | — |
| Melinta 306 Study Site | DeBary | Florida | 32713 | — |
| Melinta 306 Study Site | DeLand | Florida | 32720 | — |
| Melinta 306 Study Site | Fort Myers | Florida | 33901 | — |
| Melinta 306 Study Site | Miami | Florida | 33126 | — |
| Melinta 306 Study Site | Miami | Florida | 33185 | — |
| Melinta 306 Study Site | Louisville | Kentucky | 40202 | — |
| Melinta 306 Study Site | Natchitoches | Louisiana | 71457-6215 | — |
| Melinta 306 Study Site | Baltimore | Maryland | 21201 | — |
| Melinta 306 Study Site | Boston | Massachusetts | 02115 | — |
| Melinta 306 Study Site | Burlington | Massachusetts | 01805 | — |
| Melinta 306 Study Site | Saint Paul | Minnesota | 55104 | — |
| Melinta 306 Study Site | St Louis | Missouri | 63110 | — |
| Melinta 306 Study Site | Butte | Montana | 59701 | — |
| Melinta 306 Study Site | Omaha | Nebraska | 68124 | — |
| Melinta 306 Study Site | Newark | New Jersey | 07102 | — |
| Melinta 306 Study Site | Buffalo | New York | 14215 | — |
| Melinta 306 Study Site | Charlotte | North Carolina | 28203 | — |
| Melinta 306 Study Site | Cleveland | Ohio | 44106-5029 | — |
| Melinta 306 Study Site | Dayton | Ohio | 45402 | — |
| Melinta 306 Study Site | Rapid City | South Dakota | 57702 | — |
| Melinta 306 Study Site | Franklin | Tennessee | 37067 | — |
| Melinta 306 Study Site | Corsicana | Texas | 75110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02679573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02679573 live on ClinicalTrials.gov.